- Location
1
result for "
partial seizure
"-
Supernus Pharmaceuticals Has Received Approval From The FDA for Its Oxtellar XR
Dec 4, 2012Supernus Pharmaceuticals has received approval from the FDA for its Oxtellar XR, a new once-daily extended release formulation of oxcarbazepine. Oxtellar XR is an antiepileptic drug used as an adjunct therapy to treat partial seizures in ...
Tags: oxcarbazepine, FDA approval, partial seizure, pharmaceutical product
